Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2002 1
2003 1
2006 2
2007 6
2008 1
2009 2
2010 2
2011 1
2013 2
2014 5
2015 2
2016 2
2017 2
2022 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

27 results

Results by year

Filters applied: . Clear all
Page 1
New genetic loci link adipose and insulin biology to body fat distribution.
Shungin D, Winkler TW, Croteau-Chonka DC, Ferreira T, Locke AE, Mägi R, Strawbridge RJ, Pers TH, Fischer K, Justice AE, Workalemahu T, Wu JMW, Buchkovich ML, Heard-Costa NL, Roman TS, Drong AW, Song C, Gustafsson S, Day FR, Esko T, Fall T, Kutalik Z, Luan J, Randall JC, Scherag A, Vedantam S, Wood AR, Chen J, Fehrmann R, Karjalainen J, Kahali B, Liu CT, Schmidt EM, Absher D, Amin N, Anderson D, Beekman M, Bragg-Gresham JL, Buyske S, Demirkan A, Ehret GB, Feitosa MF, Goel A, Jackson AU, Johnson T, Kleber ME, Kristiansson K, Mangino M, Leach IM, Medina-Gomez C, Palmer CD, Pasko D, Pechlivanis S, Peters MJ, Prokopenko I, Stančáková A, Sung YJ, Tanaka T, Teumer A, Van Vliet-Ostaptchouk JV, Yengo L, Zhang W, Albrecht E, Ärnlöv J, Arscott GM, Bandinelli S, Barrett A, Bellis C, Bennett AJ, Berne C, Blüher M, Böhringer S, Bonnet F, Böttcher Y, Bruinenberg M, Carba DB, Caspersen IH, Clarke R, Daw EW, Deelen J, Deelman E, Delgado G, Doney AS, Eklund N, Erdos MR, Estrada K, Eury E, Friedrich N, Garcia ME, Giedraitis V, Gigante B, Go AS, Golay A, Grallert H, Grammer TB, Gräßler J, Grewal J, Groves CJ, Haller T, Hallmans G, Hartman CA, Hassinen M, Hayward C, Heikkilä K, Herzig KH, Helmer Q, Hi… See abstract for full author list ➔ Shungin D, et al. Nature. 2015 Feb 12;518(7538):187-196. doi: 10.1038/nature14132. Nature. 2015. PMID: 25673412 Free PMC article.
Development of a comprehensive approach to adult hereditary cancer testing in Ontario.
Bell KA, Kim R, Aronson M, Gillies B, Ali Awan A, Chun K, Hart J, Healey R, Kim L, Klaric G, Panabaker K, Sabatini PJB, Sadikovic B, Selvarajah S, Smith AC, Stockley TL, Vaags AK, Eisen A, Pollett A, Feilotter H. Bell KA, et al. J Med Genet. 2023 Aug;60(8):769-775. doi: 10.1136/jmg-2022-108945. Epub 2022 Dec 23. J Med Genet. 2023. PMID: 36564171
This, coupled with new knowledge about risk genes, necessitated a coordinated approach to expanding the scope of genes and indications tested and synchronisation of access and test utilisation across the province as required in a publicly funded universal healthcare system. METHO …
This, coupled with new knowledge about risk genes, necessitated a coordinated approach to expanding the scope of genes and indications teste …
Single-agent interleukin-2 in the treatment of metastatic melanoma: a systematic review.
Petrella T, Quirt I, Verma S, Haynes AE, Charette M, Bak K; Melanoma Disease Site Group of Cancer Care Ontario's Program in Evidence-based Care. Petrella T, et al. Cancer Treat Rev. 2007 Aug;33(5):484-96. doi: 10.1016/j.ctrv.2007.04.003. Epub 2007 Jun 11. Cancer Treat Rev. 2007. PMID: 17562357 Review.
CONCLUSION: This systematic review suggests that patients with a good performance status (ECOG 0-1), a normal lactate dehydrogenase level, less than three organs involved or cutaneous and/or subcutaneous metastases, have the highest probability of responding and achieving a durab …
CONCLUSION: This systematic review suggests that patients with a good performance status (ECOG 0-1), a normal lactate dehydrogenase level, l …
Rituximab in lymphoma: a systematic review and consensus practice guideline from Cancer Care Ontario.
Cheung MC, Haynes AE, Meyer RM, Stevens A, Imrie KR; Members of the Hematology, Disease Site Group of the Cancer Care Ontario Program in Evidence-Based Care. Cheung MC, et al. Cancer Treat Rev. 2007 Apr;33(2):161-76. doi: 10.1016/j.ctrv.2006.10.005. Epub 2007 Jan 22. Cancer Treat Rev. 2007. PMID: 17240533 Review.
We aimed to systematically review the literature on rituximab in non-Hodgkin's lymphoma and provide consensus guidelines as to the rational use of this agent. Validated methodology from the Cancer Care Ontario Program in Evidence-Based …
We aimed to systematically review the literature on rituximab in non-Hodgkin's lymphoma and provide consensus guidelines as to the rational …
High-intensity focused ultrasound for prostate cancer: a systematic review.
Lukka H, Waldron T, Chin J, Mayhew L, Warde P, Winquist E, Rodrigues G, Shayegan B; Genitourinary Cancer Disease Site Group of Cancer Care Ontario's Program in Evidence-Based Care. Lukka H, et al. Clin Oncol (R Coll Radiol). 2011 Mar;23(2):117-27. doi: 10.1016/j.clon.2010.09.002. Epub 2010 Oct 6. Clin Oncol (R Coll Radiol). 2011. PMID: 20932728 Review.
High-intensity focused ultrasound (HIFU) has recently been promoted as a non-invasive treatment option for prostate cancer. This systematic review sought to evaluate the evidence comparing it with standard treatment in patients with localised prostate cancer. The li …
High-intensity focused ultrasound (HIFU) has recently been promoted as a non-invasive treatment option for prostate cancer. This syst …
Guideline for referral of patients with suspected colorectal cancer by family physicians and other primary care providers.
Del Giudice ME, Vella ET, Hey A, Simunovic M, Harris W, Levitt C. Del Giudice ME, et al. Can Fam Physician. 2014 Aug;60(8):717-23, e383-90. Can Fam Physician. 2014. PMID: 25122815 Free PMC article. Review.
OBJECTIVE: The aim of this guideline is to assist FPs and other primary care providers with recognizing features that should raise their suspicions about the presence of colorectal cancer (CRC) in their patients. COMPOSITION OF THE COMMITTEE: Committee members were …
OBJECTIVE: The aim of this guideline is to assist FPs and other primary care providers with recognizing features that should raise th …
Guideline for referral of patients with suspected lung cancer by family physicians and other primary care providers.
Del Giudice ME, Young SM, Vella ET, Ash M, Bansal P, Robinson A, Skrastins R, Ung Y, Zeldin R, Levitt C. Del Giudice ME, et al. Can Fam Physician. 2014 Aug;60(8):711-6, e376-82. Can Fam Physician. 2014. PMID: 25122814 Free PMC article. Review.
OBJECTIVE: The aim of this guideline is to assist FPs and other primary care providers with recognizing features that should raise their suspicions about the presence of lung cancer in their patients. COMPOSITION OF THE COMMITTEE: Committee members were selected fro …
OBJECTIVE: The aim of this guideline is to assist FPs and other primary care providers with recognizing features that should raise th …
Yttrium 90 ibritumomab tiuxetan in lymphoma.
Cheung MC, Haynes AE, Stevens A, Meyer RM, Imrie K; Members of the Hematology Disease Site Group of the Cancer Care Ontario Program in Evidence-Based Care. Cheung MC, et al. Leuk Lymphoma. 2006 Jun;47(6):967-77. doi: 10.1080/10428190600572582. Leuk Lymphoma. 2006. PMID: 16840185 Review.
Initial studies of 90Y-ibritumomab tiuxetan in non-Hodgkin's lymphoma (NHL) have suggested benefit in patients with relapsed or refractory indolent disease. However, the routine adoption of this agent is tempered by concerns of associated toxicities and unclear long-term b …
Initial studies of 90Y-ibritumomab tiuxetan in non-Hodgkin's lymphoma (NHL) have suggested benefit in patients with relapsed or refractory i …
Continuous versus intermittent chemotherapy strategies in metastatic colorectal cancer: a systematic review and meta-analysis.
Berry SR, Cosby R, Asmis T, Chan K, Hammad N, Krzyzanowska MK; Cancer Care Ontario's Gastrointestinal Disease Site Group. Berry SR, et al. Ann Oncol. 2015 Mar;26(3):477-85. doi: 10.1093/annonc/mdu272. Epub 2014 Jul 23. Ann Oncol. 2015. PMID: 25057174 Free article. Review.
BACKGROUND: An important goal of intermittent strategies of delivering systemic treatment as first-line treatment of metastatic colorectal cancer (mCRC) is to maintain efficacy while improving patients' quality of life (QoL). ...
BACKGROUND: An important goal of intermittent strategies of delivering systemic treatment as first-line treatment of metastatic colorectal …
A meta-analysis and systematic review of thalidomide for patients with previously untreated multiple myeloma.
Hicks LK, Haynes AE, Reece DE, Walker IR, Herst JA, Meyer RM, Imrie K; Hematology Disease Site Group of the Cancer Care Ontario Program in Evidence-based Care. Hicks LK, et al. Cancer Treat Rev. 2008 Aug;34(5):442-52. doi: 10.1016/j.ctrv.2008.02.003. Epub 2008 Apr 1. Cancer Treat Rev. 2008. PMID: 18381234 Review.
Medline, Embase, Cochrane Controlled Trials Register, and abstracts from the American Society of Hematology and the American Society of Clinical Oncology were searched for randomized controlled trials (RCTs) of either induction or maintenance thalidomide in adults with pre …
Medline, Embase, Cochrane Controlled Trials Register, and abstracts from the American Society of Hematology and the American Society …
27 results